Attana receives contract research order from a global pharma company
Attana has received ontract research order from an global pharma company with headquarter in Europe. The contract is the results of the previous performed experiments for the pharma company, but from a new orginisational unit and within a different area. The experiments are based on Attana’s patented biosensor and will included detailed interaction charaterization of the drug molecule.Attana’s application specialists will perform experiments where different interactions at different conditions will be studied. It is a smaller contract, but with a potential for further contract later on.